US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

40.72

+0.25340.63%

Volume:9K

Turnover:379.04K

Market Cap:1.05B

PE:- -

High:40.89

Open:40.73

Low:40.57

Close:40.47

52wk High:42.87

52wk Low:27.30

Shares:25.75M

Float Shares:25.75M

Volume Ratio:0.34

T/O Rate:0.04%

Dividend:0.42

Dividend Rate:1.04%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Growth Without AI: 8 Stock Picks

Top Bristol-Myers Squibb Executive Makes Major Move With Insider Stock Sale

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi Disposes of 6,249 Common Shares Worth $403,700.93

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Champions Oncology Q1 Revenue Rises on Research Services Business

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS

BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod

Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors

Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says

MT Newswires Live

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/FTXH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":40.72,"timestamp":1789416000000,"preClose":40.4666,"halted":0,"volume":9304,"delay":0,"changeRate":0.006261954303054845,"floatShares":25750002,"shares":25750002,"eps":0,"marketStatus":"Pre-Mkt","change":0.2534,"latestTime":"09-15 07:37:41 EDT","open":40.73,"high":40.89,"low":40.57,"amount":379041.75012,"amplitude":0.007908,"askPrice":40.73,"askSize":1,"bidPrice":39.82,"bidSize":800,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.72,"sharesOutstanding":850002,"nav":40.41,"aum":1040557580.82,"dividendRate":0.0104,"bidAskSpread":0.001731,"postHourTrading":{"tag":"盘后","latestPrice":40.72,"preClose":40.72,"latestTime":"19:30 EDT","volume":9,"amount":366.48,"timestamp":1789428605981,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3432551678634409,"impliedVol":0.059,"impliedVolPercentile":0.516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3432551678634409,"shares":25750002,"dividePrice":0.4235,"high":40.89,"amplitude":0.007908,"preClose":40.4666,"low":40.57,"week52Low":27.3,"pbRate":"--","week52High":42.87,"institutionHeld":0,"latestPrice":40.72,"committee":0.997503,"eps":0,"divideRate":0.0104,"volume":9304,"delay":0,"ttmEps":0,"open":40.73,"prevYearClose":32.9401,"prevWeekClose":40.4666,"prevMonthClose":41.3525,"prevQuarterClose":38.1897,"fiveDayClose":41.7742,"twentyDayClose":39.7951,"sixtyDayClose":35.6377},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FTXH","amount":0.0892,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666216595","title":"Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666216595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666216595?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:40","pubTimestamp":1789126806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Adagene (ADAG), AbbVie (ABBV) and Definium Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-adagene-adag-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-adagene-adag-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689626769.HKD","LU1037948897.HKD","ABBV","JDOC","LU1074936037.SGD","MEDX","LU0098860793.USD","RXL","LU0726765562.USD","LU2433249047.HKD","XLV","LU0417517546.SGD","LABU","FHLC","XBI","IXJ","PJP","LU1057294990.SGD","LU0661504455.SGD","LU1496350502.SGD","LU1923622614.USD","LU0289739699.SGD","LU1061106388.HKD","LU1732799900.SGD","LU2125909247.SGD","IE00B42XCP33.USD","LU0708994859.HKD","LU2023251221.USD","IE00BFTCPJ56.SGD","TRUH","FTXH","SG9999011175.SGD","LU1983299246.USD","IE0002270589.USD","PPH","LU0795875169.SGD","IE0002141913.USD","AGNG","BK4559","VHT","ADAG","IYH","HCSG","LU1934455863.HKD","IE00B2B36J28.USD","IE0009355771.USD","LU0820561818.USD","LU2347655073.USD","GLAM","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666281529","title":"Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666281529","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666281529?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:24","pubTimestamp":1789125860,"startTime":"0","endTime":"0","summary":"Merck (MRK) has an average rating of overweight and mean price target of $153.04, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0477156953.USD","TRUH","LU1116320737.USD","LU1917777945.USD","LU0208291251.USD","BMED","IE0002141913.USD","LU1934455194.USD","FHLC","LU1989772923.USD","LU0320765646.SGD","BK4585","LU1116320901.HKD","LU0868494708.USD","PAWZ","LU2361044865.SGD","SG9999015358.SGD","LU1430594728.SGD","LU0203347892.USD","BK4534","IXJ","LU0648001328.SGD","IE0009355771.USD","LU1923622614.USD","LU0238689110.USD","LU1093756325.SGD","SGXZ57979304.SGD","PPH","BK4559","LU1983299246.USD","LU2089984988.USD","GDOC","LU0130517989.USD","LU1929549753.HKD","IE00BBT3K403.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2468319806.SGD","LU0289739699.SGD","LU2324357040.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","LU0965509283.SGD","LU2125909247.SGD","IE00B2B36J28.USD","IE00BLSP4452.SGD","IE00B1BXHZ80.USD","LU0070302665.USD","LU2491050154.USD","LU1934455277.USD","MRK","FTXH","LU0266013472.USD","LU2433249047.HKD","SG9999014575.USD","LU2361045086.USD","LU2112291526.USD","LU1989772840.SGD","LU0942090050.USD","LU2023250504.SGD","IE00BSNM7G36.USD","SG9999014542.SGD","BK4550","LU0130102774.USD","LU2125154778.USD","IE00B4R5TH58.HKD","SG9999013999.USD","IE00BLSP4239.USD","LU2106854487.HKD","IYH","LU0124676726.USD","SG9999001176.USD","LU0098860793.USD","LU2491050071.SGD","LU1201861249.SGD","LU1032466523.USD","LU0122379950.USD","LU1037948897.HKD","LU1057294990.SGD","LU0265550946.USD","LU0265550359.USD","LU1571399168.USD","LU1934455863.HKD","LU1941712348.USD","LU2023250843.SGD","IE00BJT1NW94.SGD","LU0965509010.AUD","BK4588","LU2125909593.SGD","LU0106261372.USD","RXL","SG9999002232.USD","LU1699723380.USD","XLV","LU1066051225.USD","SG9999001440.SGD","HRTS","SG9999001176.SGD","SG9999014559.SGD","LU1162221912.USD","LU0689626769.HKD","BK4516","LU0432979614.USD","BK4533","LU2125154935.USD","LU2491049909.HKD","SG9999002224.SGD","LU0868494617.USD","LU1066053197.SGD","LU0861579265.USD","BK4007","LU1066051498.USD","LU0965509101.SGD","LU0320765489.SGD","LU1066051811.HKD","LU1974910355.USD","LU0965508806.USD","LU1989771016.USD","LU2357627491.SGD","LU0859254822.USD","LU2461242641.AUD","LU1585245621.USD","LU1069347547.HKD","JDOC","LU0234572021.USD","LU1061106388.HKD","LU1093756168.USD","VHT","LU0006306889.USD","LU0211331839.USD","SG9999014567.USD","LU1023059063.AUD","LU0203345920.USD","LU1941712264.USD","IE000M9KFDE8.USD","IHE","LU0823416689.USD","LU1035773651.USD","IE00BN8TJ469.HKD","LU0980610538.SGD","SG9999015341.SGD","LU0985320562.USD","LU1037948541.HKD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666422435","title":"Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666422435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666422435?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:20","pubTimestamp":1789114812,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moderna (MRNA), Merck & Company (MRK) and Pacific ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PACB","LU0965509101.SGD","LU1037948897.HKD","VHT","IE00BJT1NW94.SGD","LU0203345920.USD","IE0009355771.USD","LU0208291251.USD","RXL","LU2023250843.SGD","LU1066051498.USD","IE00B4R5TH58.HKD","LU0006306889.USD","LU0965508806.USD","LU2125154778.USD","LU1585245621.USD","PPH","LU0070302665.USD","LU1941712348.USD","LGHT","GNOM","LU2360032135.SGD","LU1037948541.HKD","LU0868494617.USD","LU1430594728.SGD","LU1116320737.USD","BK4548","IE00B1BXHZ80.USD","LU2461242641.AUD","MRNA","SG9999002232.USD","LU1066051225.USD","HRTS","LU2491049909.HKD","LU2023250504.SGD","LU0124676726.USD","LU2491050154.USD","GDOC","LU1066051811.HKD","LU0203347892.USD","LU1989772923.USD","LU1023059063.AUD","LU0289739699.SGD","LU0058720904.USD","IE00BLSP4239.USD","LU2433249047.HKD","LU2324357040.USD","IHE","FTXH","LU1069347547.HKD","LU2112291526.USD","PAWZ","BK4516","LU0823416689.USD","BK4139","LU2125909247.SGD","LU0238689110.USD","IE00B2B36J28.USD","LU0265550946.USD","LU1917777945.USD","LU1934455194.USD","BK4532","IE0002141913.USD","LU0098860793.USD","LU0130102774.USD","IE00BJJMRZ35.SGD","LU2357627491.SGD","IE00BLSP4452.SGD","JDOC","BK4551","LU1162221912.USD","LU1571399168.USD","LU1929549753.HKD","LU1989771016.USD","IE00BSNM7G36.USD","LU0106261372.USD","LU1116320901.HKD","LU1934455863.HKD","LU0477156953.USD","LU0868494708.USD","IXJ","BK4559","SG9999015358.SGD","BK4585","LU0648001328.SGD","LU0211331839.USD","LU1974910355.USD","LU0266013472.USD","LU0942090050.USD","IDNA","BK4588","WDNA","LU0985320562.USD","LU1989772840.SGD","LU0965509283.SGD","LU0320765489.SGD","SG9999014567.USD","SG9999002224.SGD","BK4533","LU1201861249.SGD","LU0265550359.USD","BK4501","BMED","LU0965509010.AUD","LU1066053197.SGD","IE00BN8TJ469.HKD","IE000M9KFDE8.USD","LU1032466523.USD","TRUH","SG9999014575.USD","LU1699723380.USD","LU0861579265.USD","BK4534","LU1934455277.USD","LU1941712264.USD","MRNX","LU2361044865.SGD","LU1093756325.SGD","SG9999014559.SGD","IE00BBT3K403.USD","IYH","LU1093756168.USD","LU0234572021.USD","SG9999001440.SGD","LU0859254822.USD","SG9999014542.SGD","LU2125154935.USD","LU1057294990.SGD","LU0432979614.USD","BK4568","LU1291159041.SGD","SG9999013999.USD","LU0689626769.HKD","LU2125909593.SGD","MRK","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0980610538.SGD","LU1035773651.USD","LU1923622614.USD","LU1983299246.USD","LU2106854487.HKD","SG9999001176.SGD","BK4121","BK4007","LU0130517989.USD","SGXZ57979304.SGD","LU2468319806.SGD","MRNY","LU0122379950.USD","SG9999001176.USD","LU0320765646.SGD","FHLC","LU2491050071.SGD","LU2361044949.HKD","BK4550","SG9999015341.SGD","LU1061106388.HKD","LU2361045086.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666362544","title":"MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2666362544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666362544?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:30","pubTimestamp":1789111803,"startTime":"0","endTime":"0","summary":"BUZZ-MS cuts Novo Nordisk on growth prospects, patent expiry risks** Morgan Stanley downgrades Danish drugmaker Novo NordiskNOVOb.COto \"underweight\" from \"equal weight\", citing subdued medium-term growth prospects and a significant loss-of-exclusivity risk for semaglutide in the early 2030s** The broker notes the stock trades at a demanding premium that fails to reflect a looming patent cliff for its diabetes and weight loss drug semaglutide** Morgan Stanley also points to recent U.S. prescription trends and proprietary survey data indicating Novo is losing market share in diabetes and obesity to Eli Lilly'sLLY.Ntreatments** The brokerage adds that anticipated sales from the upcoming oral obesity franchise will likely not be enough to offset increasing pricing pressures and competition** Novo Nordisk shares slip 2.4%, sitting among the worst performers on the STOXX 600.STOXX** Out of 32 analysts, eight rate Novo \"strong buy\" or \"buy\", 21 \"hold\" and three \"strong sell\" or \"sell\" - LSEG ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4530EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","LU0320765059.SGD","LU1061106388.HKD","LU1280957306.USD","LU0823434740.USD","LU2471134879.HKD","LU2746668461.USD","CURE","AGNG","BK4007","LU2462591350.SGD","LU0174119429.USD","IE00B7KXQ091.USD","LU1548497426.USD","SG9999018865.SGD","TRUH","LU1720051017.SGD","IE00BFSS7M15.SGD","LU2237443549.SGD","LLII","IE00BFTCPJ56.SGD","LU0225283273.USD","LLYZ","NVOX","LU0114720955.EUR","LU1064131342.USD","ELIL","LU1093756168.USD","LU0456855351.SGD","LU2237443382.USD","SG9999014880.SGD","LU2237443622.USD","LU1551013342.USD","JDOC","FHLC","LU1720051108.HKD","LU1232071149.USD","IE00B4JS1V06.HKD","LU2237443465.HKD","SG9999015952.SGD","SG9999015986.USD","LU0203201768.USD","LU2491049909.HKD","LU2746668974.SGD","LU0122379950.USD","LU1023059063.AUD","LU2552382215.SGD","CANC","LU0234572021.USD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1145028129.USD","PPH","MEDI","LU0640476718.USD","THNR","LU0323591593.USD","IE0009355771.USD","SG9999001176.USD","LU1069344957.HKD","IE00BKPKM429.USD","LU0109394709.USD","LU1868836757.USD","IE00BZ1G4Q59.USD","LU2471134796.USD","SGXZ99366536.SGD","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU2237443895.HKD","LU2237443978.SGD","LU0786609619.USD","LU1629891620.HKD","LU2750360997.AUD","IE00BN29S564.USD","LU0353189763.USD","PJP","IE00B4R5TH58.HKD","LU0198837287.USD","LU2028103732.USD","LU0256863902.USD","SGXZ31699556.SGD","LU2271345857.HKD","LU1979441026.SGD","LU0432979614.USD","LU2357305700.SGD","RXL","LU2750360641.GBP","IE00BWXC8680.SGD","IE0005OL40V9.USD","LLY","IE00BJLML261.HKD","BK4599","LU0158827781.USD","LU1804176565.USD","LU1868836914.USD","NVOH","LU2471134952.CNY","LU2756315664.SGD","OZEM","LU0158827948.USD","TMED","XLV","LU2106854487.HKD","LU2491050154.USD","LU2089284900.SGD","LU2213496289.HKD","LU1127390331.HKD","LU2756315318.SGD","WDNA","LU0466842654.USD","LU0079474960.USD","LU1267930730.SGD","LU2211815571.USD","SGXZ51526630.SGD","LU2168564065.EUR","LU2456880835.USD","LU1691799644.USD","LU1551013425.SGD","LU0672654240.SGD","LU2360106947.USD","LU2471134523.USD","LU0471298777.SGD","LU2112291526.USD","LU1988902786.USD","BK4534","LU1057294990.SGD","LU0133085943.USD","LU0203202063.USD","LU0471298694.HKD","LU0964807845.USD","LU2168564149.EUR","LU2461242641.AUD","LU0689472784.USD","LU2552382132.HKD","LU0238689110.USD","LU0345770993.USD","GDOC","IYH","LU0385154629.USD","LU2089283258.USD","LU0266013472.USD","LU0820562030.AUD","SG9999014914.USD","LU2168563687.JPY","LU1868836591.USD","LU0289739699.SGD","LU0094547139.USD","LU2324357040.USD","LU2111349929.HKD","IE00BKVL7J92.USD","LU0256863811.USD","LU0353189680.USD","LU1093756325.SGD","MEDX","LU0683600562.USD","LU2108987350.USD","LU2361045086.USD","LU1989771016.USD","MHIP","SG9999014898.SGD","LU2236285917.USD","NVO","SG9999015945.SGD","ILDR","LU0417517546.SGD","LU0354030511.USD","LU0882574055.USD","BK4588","LU1323610961.USD","LU2023250330.USD","LU2168564222.USD","LU2491050071.SGD","ELIS","LU0820561818.USD","LU2361044865.SGD","LU0106261372.USD","SG9999001176.SGD","LU0109391861.USD","LU0154236417.USD","FTXH","LU0823434583.USD","LU0210536198.USD","LU1035775433.USD","IXJ","LU0320765992.SGD","LU2023251221.USD","LU2265009873.SGD","LU0354030438.USD","IE00BKDWB100.SGD","LU0316494557.USD","LU1917777945.USD","LU2237438978.USD","IE00BJT1NW94.SGD","LU0058720904.USD","BK4516","BK4532","LU0345770308.USD","LU1291159041.SGD","LU1814569148.SGD","LU2361044949.HKD","LU2552382058.USD","IE00B1BXHZ80.USD","LU0006306889.USD","LU1974910355.USD","LLYX","IE0004445239.USD","NVOC","LU2168564495.EUR","LU0787776722.HKD","LU1366192091.USD","LU0943347566.SGD","IE00B775H168.HKD","LU2089984988.USD","SG9999018857.SGD","LU2063271972.USD","LU2468319806.SGD","LU0061475181.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU2462157665.USD","BK4585","BK4581","LU1868837136.USD","LU0882574139.USD","LU0096364046.USD","HRTS","GB00BDT5M118.USD","LU2264538146.SGD","VHT","SG9999015978.USD","LU0820561909.HKD","IE0004445015.USD","SG9999014906.USD","SG9999013999.USD","LU0823416689.USD","IE00BFSS8Q28.SGD","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","IE00BJJMRX11.SGD","LU2023250504.SGD","LU2602419157.SGD","IHE","IE00BK4W5M84.HKD","LU0708995401.HKD","IE00B1XK9C88.USD","BK4533","LU0097036916.USD","LU1623119135.USD","SG9999017495.SGD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666543244","title":"Growth Without AI: 8 Stock Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2666543244","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666543244?lang=en_us&edition=fundamental","pubTime":"2026-09-11 13:00","pubTimestamp":1789102800,"startTime":"0","endTime":"0","summary":"War in the Middle East has driven up marine fuel costs. Will it also dampen European wanderlust?And will red tape delay the opening of Royal's Perfect Day Mexico, the next pillar in the company's lucrative private-island model, from late next year into 2028?Our best guesses: Supply looks manageable, strength in Nort","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU1668664300.SGD","LU2324357040.USD","LU0048573561.USD","BK4581","BK4597","SG9999014898.SGD","LU1720051108.HKD","LU0943347566.SGD","LU2089283258.USD","LU1974910355.USD","TRUH","SG9999015952.SGD","SGXZ99366536.SGD","LU0787776722.HKD","LU0823434583.USD","IE00B1BXHZ80.USD","VHT","IE00B7KXQ091.USD","LU2471134796.USD","LU0256863811.USD","LU0354030438.USD","LU0708995401.HKD","BK4200","LU1868837300.USD","LU2063271972.USD","LU0820562030.AUD","IE00BFSS7M15.SGD","MEDI","LU0320765059.SGD","LU2089284900.SGD","IE00BKPKM429.USD","SG9999015986.USD","SGXZ57979304.SGD","BK4588","LU0289739699.SGD","WDNA","LU0466842654.USD","THNR","IE00BK4W5M84.HKD","IE00B1XK9C88.USD","IE00B19Z3B42.SGD","IE00BWXC8680.SGD","LU0321505439.SGD","LU2106854487.HKD","LU0203201768.USD","IE00B19Z3581.USD","LU2471134952.CNY","FIVE","BK4142","LU2089984988.USD","LU0122379950.USD","BK4585","IE00BFSS8Q28.SGD","LU0345774631.USD","LU2361044949.HKD","LU0689472784.USD","LU0306807586.USD","LU2023250330.USD","SG9999014005.SGD","LU1323610961.USD","LU1868836757.USD","LU1267930573.SGD","LU1035773651.USD","SGXZ81514606.USD","IXJ","LU1064131342.USD","LLY","LU1691799644.USD","MHIP","IE00B2B36J28.USD","LU2746668461.USD","IHE","LU1548497426.USD","LU0742534661.SGD","LU1670628061.USD","SG9999014914.USD","LU0477156953.USD","LU2168564495.EUR","LU0158827781.USD","SG9999013999.USD","BK4517","LU1035775433.USD","IE0005OL40V9.USD","SG9999014013.SGD","LU0640476718.USD","LU1861217088.USD","LU2746668974.SGD","IE00BFTCPJ56.SGD","LU1201861249.SGD","IYH","LU2237443382.USD","LU0225283273.USD","LU2417539215.USD","LU0029864427.USD","LU0225771236.USD","SG9999015978.USD","LU0174119429.USD","LU0345774391.USD","LU2211815571.USD","IE00BJJMRZ35.SGD","LU2023251221.USD","IE00BJLML261.HKD","LU0058720904.USD","MEDX","LU0985481810.HKD","LU0964807845.USD","IE0002141913.USD","IE0004445239.USD","LU0094547139.USD","LLII","LU0471298694.HKD","LU2462591350.SGD","LU2750360997.AUD","LU0198837287.USD","SG9999001176.SGD","LU0316494557.USD","LU1917777945.USD","LU0097036916.USD","LU0385154629.USD","LU0256863902.USD","LU2236285917.USD","GDOC","SG9999017495.SGD","SG9999018857.SGD","LU2360106947.USD","LU1720051017.SGD","CURE","LU2237438978.USD","LU0354030511.USD","IE00B4JS1V06.HKD","BK4127","LU0786609619.USD","LU0417517546.SGD","BK4504","LU2112291526.USD","LU0238689110.USD","LU0109391861.USD","JDOC","LU1057294990.SGD","LU0130517989.USD","BK4589","IE0002270589.USD","LU0251131958.USD","LU1791807156.HKD","LU0320765992.SGD","LU1127390331.HKD","LU1074936037.SGD","LU0306806265.USD","BK4139","FTXH","LU0672654240.SGD","LU1868836914.USD","BK4534","IE00B4R5TH58.HKD","GB00BDT5M118.USD","IE00BJJMRY28.SGD","LU1712237335.SGD","BMRN","LU1983299246.USD","LU2756315664.SGD","LU0133085943.USD","IE0001KFT4U8.USD","SGXZ31699556.SGD","LU2237443622.USD","LU2087625088.SGD","LU1061106388.HKD","LU2361044865.SGD","LU2552382058.USD","IE00B775H168.HKD","SGXZ51526630.SGD","LU1069344957.HKD","LU1804176565.USD","LU0471298777.SGD","PPH","LU1814569148.SGD","BK4533","ELIL","SG9999001176.USD","IE00BK4W5L77.USD","LU0882574139.USD","LU0251142724.SGD","LU1363072403.SGD","LU1861220207.SGD","SG9999001077.SGD","SG9999018865.SGD","BK4161","LU0109394709.USD","LU2265009873.SGD","LU1868836591.USD","LU2461242641.AUD","LU2750360641.GBP","LU0353189763.USD","LU0130102774.USD","LU2111349929.HKD","LU0820561909.HKD","WNDR","LU1670627923.USD","LU0210536198.USD","IE000M9KFDE8.USD","LU0353189680.USD","ILDR","LU2471134523.USD","LU0321505868.SGD","IE00BJJMRX11.SGD","LU2360107671.USD","LU2462157665.USD","LU0266013472.USD","LU2237443895.HKD","LU0310800379.SGD","LU1979441026.SGD","FHLC","LU1989771016.USD","LU2168563687.JPY","BK4566","LU0225284248.USD","LU2552382215.SGD","LU0006306889.USD","LU1551013425.SGD","LU0158827948.USD","LU1153585028.USD","LU1093756168.USD","LU0106831901.USD","LU2237443549.SGD","IE0004445015.USD","LU2028103732.USD","LU1145028129.USD","LU0234572021.USD","LU1988902786.USD","LU2491049909.HKD","LU2237443465.HKD","LU0106261372.USD","SG9999014906.USD","LU1093756325.SGD","LU2602419157.SGD","LU0128525929.USD","LU1551013342.USD","LU2361045086.USD","SG9999014021.USD","LU0889565916.HKD","IE00BKDWB100.SGD","IE00BN29S564.USD","SWK","LU1069347547.HKD","LU1623119135.USD","LU0114720955.EUR","OZEM","LU2357305700.SGD","LU0079474960.USD","LU0323591593.USD","LU2552382132.HKD","TMED","LU2237443978.SGD","ELIS","BK4599","LU0345770993.USD","LU2491050071.SGD","LU1280957306.USD","LU0096364046.USD","LU1232071149.USD","IE0009355771.USD","LLYX","LU1868837136.USD","LU1366192091.USD","LU2264538146.SGD","LU0882574055.USD","IAI","RCL","LU2108987350.USD","LU0823434740.USD","SCHW","LU0980610538.SGD","LU2168564065.EUR","LU2213496289.HKD","LU2471134879.HKD","LU0011850046.USD","LU2468319806.SGD","LU2168564222.USD","BK4516","SG9999014880.SGD","LU1629891620.HKD","LU0823416689.USD","BK4007","LU2756315318.SGD","SG9999014039.USD","LU2023250504.SGD","SG9999015945.SGD","LU1267930730.SGD","LU1291159041.SGD","LLYZ","LU2491050154.USD","LU1023059063.AUD","LU2271345857.HKD","LU0061475181.USD","PJP","LU2896262040.SGD","LU0708994859.HKD","RXL","LU2168564149.EUR","LU0971096721.USD","LU0648001328.SGD","IE00B7SZLL34.SGD","LU2456880835.USD","LU0432979614.USD","AGNG","CANC","LU0345770308.USD","LU0203202063.USD","LU0820561818.USD","HRTS","LU0683600562.USD","XLV","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666921517","title":"Top Bristol-Myers Squibb Executive Makes Major Move With Insider Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666921517","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666921517?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:01","pubTimestamp":1789092072,"startTime":"0","endTime":"0","summary":"New insider activity at Bristol-Myers Squibb ( ($BMY) ) has taken place on September 10, 2026. Cristian Massacesi, Executive Vice President, Chief ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-bristol-myers-squibb-executive-makes-major-move-with-insider-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-bristol-myers-squibb-executive-makes-major-move-with-insider-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1670711040.USD","LU1670711123.USD","LU0061475181.USD","LU1093756168.USD","LU1291159041.SGD","LU0225771236.USD","IHE","LU1430594728.SGD","LU0306806265.USD","IE00B2B36J28.USD","LU1571399168.USD","BK4559","LU2133065610.SGD","LU0267386448.USD","LU1670710661.SGD","LU2125154935.USD","LU1983299246.USD","IE00BFXG1179.USD","LU0321505439.SGD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU0321505868.SGD","LU1989771016.USD","LU2596442595.SGD","IE0009355771.USD","LU0114720955.EUR","BMY","LU2242646821.SGD","BK4585","LU0868494617.USD","LU0882574055.USD","BK4534","FTXH","LU2125154778.USD","LU2242652126.USD","BK4581","LU1883839398.USD","LU1236620750.USD","LU0096364046.USD","LU1868837136.USD","IE00BJJMRZ35.SGD","LU1670710588.SGD","LU1868836757.USD","LU0237698245.USD","IE00BSNM7G36.USD","LU0985481810.HKD","LU1868837300.USD","LU1074936037.SGD","IE00BJT1NW94.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516789","title":"Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516789?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:29","pubTimestamp":1789075740,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  shed 5.23% to $13.59 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,591.70 and Dow Jones Industrial Average  falling 0.60% to 52,064.10.This was the stock's third consecutive day of losses.Perrigo Co. PLC closed 40.00% below its 52-week high of $22.65, which the company achieved on October 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 0.27% to $266.35, Procter & Gamble Co.  rose 0.23% to $142.97, and Abbott Laboratories  fell 1.78% to $103.36.Trading volume  remained 924,549 below its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","IE0002141913.USD","IYH","ABT","LU0912757837.SGD","LU1059921491.USD","LU1061106388.HKD","IE00B4R5TH58.HKD","IHE","PRGO","PG","LU1221951129.SGD","MEDX","LU0162691827.USD","RXL","IHI","IE0000B7K699.USD","FHLC","IE00BGHQF631.EUR","JDOC","LU0432979614.USD","LU1032955483.USD","BK4082","PJP","LU1244550494.USD","VHT","UGE","BK4566","SGXZ23171101.USD","FTXH","LU0882574055.USD","TMED","LU0345770308.USD","IE00BJJMRZ35.SGD","IXJ","BMED","LU0795875086.SGD","XLP","LU0124676726.USD","JNJ","TRUO","FSTA","TRUH","LU0053666078.USD","LU1989763690.USD","XLV","LU2237957811.SGD","LU2552382215.SGD","GDOC","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515059","title":"Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi Disposes of 6,249 Common Shares Worth $403,700.93","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515059","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515059?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:38","pubTimestamp":1789072682,"startTime":"0","endTime":"0","summary":"Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi disposes of 6,249 common shares worth $403,700.93Bristol-Myers Squibb EVP, Chief Medical Officer, Head of Development Cristian Massacesi so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL31NHrC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bristol Myers’ EVP, Chief Medical Officer Cristian Massacesi Disposes of 6,249 Common Shares Worth $403,700.93","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032466523.USD","LU0306807586.USD","LU0061475181.USD","LU1868836914.USD","BK4534","LU0267386448.USD","LU0321505868.SGD","LU1236620750.USD","LU2125154778.USD","LU1585245621.USD","LU2125154935.USD","LU1670711040.USD","BK4585","BK4581","LU1989771016.USD","LU1868836757.USD","LU1883839398.USD","LU1868836591.USD","FTXH","LU0237698245.USD","LU1236620834.HKD","BK4532","LU1093756168.USD","LU0985481810.HKD","IHE","LU1670710661.SGD","LU0225771236.USD","LU0456855351.SGD","LU1074936037.SGD","LU1670710588.SGD","LU2242646821.SGD","LU0882574055.USD","BMY","IE00BJJMRZ35.SGD","BK4007","LU0321505439.SGD","LU2133065610.SGD","LU0868494617.USD","IE00B2B36J28.USD","BK4588","LU2596442595.SGD","LU0306806265.USD","LU2242652126.USD","LU0432979614.USD","LU1291159041.SGD","BK4559","IE00BSNM7G36.USD","IE0002141913.USD","LU1323610961.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515425","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515425?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:31","pubTimestamp":1789072260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  rallied 1.63% to $255.00 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,591.70 and Dow Jones Industrial Average  falling 0.60% to 52,064.10.This was the stock's second consecutive day of gains.AbbVie Inc. closed 4.66% below its 52-week high of $267.47, which the company reached on July 29th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  fell 0.27% to $266.35, Pfizer Inc.  fell 0.47% to $27.65, and Amgen Inc.  fell 2.25% to $382.47.Trading volume  remained 922,509 below its 50-day average volume of 5.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","LU0310799852.SGD","LU1267930490.SGD","IE00B2B36J28.USD","LU0417517546.SGD","IYH","LU0069063385.USD","LU2089984988.USD","LU2125909247.SGD","IE00BVYPNV92.GBP","LU0122379950.USD","BK4559","LU0868494617.USD","BK4550","LU1585245621.USD","LU0820561909.HKD","LU1236620750.USD","LU1989772840.SGD","LU0234570918.USD","IXJ","LU0942090050.USD","LU1732799900.SGD","IE00BN8TJ469.HKD","LU0689626769.HKD","LU2237443895.HKD","IE000SO60NU8.SGD","LU0158827948.USD","LU1496350171.SGD","LU1037948541.HKD","LU0058720904.USD","IE0002270589.USD","IE0002141913.USD","BK4139","LU0198837287.USD","LU0943347566.SGD","LU0170899867.USD","LU1162221912.USD","LU1934455863.HKD","LU0545039389.USD","LU1732800096.USD","IE0009355771.USD","LU1551013342.USD","LU1839511570.USD","TRUH","LU1934455194.USD","LU0320765646.SGD","BK4585","LU1989771016.USD","LU1929549753.HKD","IE00BVYPNW00.USD","MEDX","LU0912757837.SGD","IE00BJT1NW94.SGD","LU1934455277.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","JDOC","LU0708994859.HKD","LU0432979614.USD","LU2237443382.USD","IE00B3PB1722.GBP","LU1057294990.SGD","LU1236620834.HKD","LU1983299246.USD","LU1093756168.USD","LU0256863902.USD","LU2237443622.USD","AGNG","SG9999003800.SGD","LU0553294199.USD","IE00BGHQF631.EUR","LU0203345920.USD","IE000MB6IJN5.SGD","LU0203347892.USD","LU1074936037.SGD","VHT","IE000F7OJYX1.SGD","IE00B42XCP33.USD","LU2089284900.SGD","LU0289961442.SGD","LU0965509101.SGD","SG9999015986.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0795875169.SGD","LU2357627491.SGD","PJP","LU0057025933.USD","LU1244550494.USD","LU2347655073.USD","SG9999015978.USD","LU2129689431.USD","BK4533","LU0098860793.USD","LU1670628061.USD","LU2087621335.USD","LU1923622614.USD","LU2112291526.USD","LU2347655156.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","LU1551013425.SGD","LU2129689605.HKD","LU0289739343.SGD","LU0124676726.USD","LU2089283258.USD","LU0689472784.USD","RXL","PPH","LU1023059063.AUD","SG9999001440.SGD","BK4588","LU0211328371.USD","IE00BLSP4452.SGD","LU0949170772.SGD","LU0256863811.USD","IE000BZT7R73.USD","LU0128525929.USD","LU1989772923.USD","IE00BLSP4239.USD","LU2125909593.SGD","IE00BDGV0183.EUR","LU2237443549.SGD","LU2433249047.HKD","BK4566","BK4534","LU1496350502.SGD","LU1244550577.SGD","LU0114720955.EUR","SG9999015945.SGD","LU0661504455.SGD","LU0511384066.AUD","IE0004445239.USD","LU1061106388.HKD","LU0029864427.USD","LU2237443978.SGD","LU0965509283.SGD","LU0859254822.USD","LU1670627923.USD","LU0211327993.USD","IE0000B7K699.USD","LU2468319806.SGD","LU0965509010.AUD","LU1093756325.SGD","LU1430594728.SGD","LU2237443465.HKD","IE000WAW04H5.SGD","IE00BFTCPJ56.SGD","BK4581","ABBV","GLAM","LU0738911758.USD","LU1267930573.SGD","LU0795875086.SGD","LU2023251221.USD","LU0868494708.USD","LU1291159041.SGD","LU0965508806.USD","LU2129689514.USD","LU1003077747.HKD","LU0882574055.USD","LU0820561818.USD","IE00BJJMRZ35.SGD","XLV","LU0823416689.USD","LU0395794307.EUR","LU2133065610.SGD","LU0985320562.USD","FTXH","LU0456855351.SGD","LU1718418525.SGD","LU0472753341.HKD","IE00B4R5TH58.HKD","LU1037948897.HKD","SG9999015952.SGD","LU1244550221.USD","SG9999011175.SGD","LU0726765562.USD","LU0861579265.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513067","title":"Champions Oncology Q1 Revenue Rises on Research Services Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513067","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513067?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071012,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 revenue rises on research services businessOverviewUS translational oncology research firm's fiscal Q1 revenue grew 8.8% yr/yrOncology services margin improved to 51% from 43% in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL1N45210N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BIB","LU3187612489.SGD","AMGN","IBBQ","LU0784384876.USD","LU1883839398.USD","LU1323610961.USD","LU0640478417.SGD","BMY","LU0203345920.USD","BBH","LU1093756168.USD","LU1084165304.USD","LU2360032135.SGD","LU0823416689.USD","LU0211327993.USD","PBE","LU1074936037.SGD","FTXH","LU1355424745.HKD","LU1868836757.USD","LU2357627491.SGD","LU0211326839.USD","LU1196032939.SGD","LU1273509221.SGD","LU2539964713.USD","LU0949170426.SGD","LU0096364046.USD","LU0171276677.USD","LU0827474353.SGD","TBXU","LU0267386448.USD","LU0211328371.USD","LU1119994496.HKD","LU1261432733.SGD","LU2293690082.USD","IHE","AZN.UK","IBB","LU1585245621.USD","LU1430594728.SGD","LU1267930573.SGD","PJP","LU1078025761.USD","LU1814569148.SGD","LU0868494617.USD","LU0321505439.SGD","LU1153584641.USD","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513650","title":"Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513650?lang=en_us&edition=fundamental","pubTime":"2026-09-11 03:50","pubTimestamp":1789069845,"startTime":"0","endTime":"0","summary":"Insight Guru flags valuation flip as Merck trades at 52.2x operating profit vs Lilly 25.3xInsight Guru analysis flagged a valuation reversal between Merck and Eli Lilly, with Merck now trading at a pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3jvMXh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","LLY","LU0943347566.SGD","LU2237443978.SGD","LU2357627491.SGD","LU1032466523.USD","LU2237443895.HKD","LU2417539215.USD","SG9999015952.SGD","LU1093756325.SGD","LU2213496289.HKD","LU0109394709.USD","LU1979441026.SGD","PAWZ","LU2462157665.USD","SG9999018865.SGD","LU2168564149.EUR","LU1923622614.USD","LU0097036916.USD","LU2461242641.AUD","LU1069347547.HKD","LU0477156953.USD","LU1814569148.SGD","LU0353189763.USD","IE00BFSS7M15.SGD","OZEM","LU0094547139.USD","LU0354030438.USD","LU1323610961.USD","IE00BKPKM429.USD","LU0689626769.HKD","LU0098860793.USD","LU2023251221.USD","BK4550","LU1291159041.SGD","IE000M9KFDE8.USD","LU2361044949.HKD","LU0208291251.USD","SG9999015341.SGD","IE00BN8TJ469.HKD","LU0385154629.USD","LU2361044865.SGD","LU0109391861.USD","LU1934455194.USD","IXJ","LU1917777945.USD","LU2552382058.USD","LU0689472784.USD","LU0265550359.USD","LU1934455277.USD","LU2125909593.SGD","IE00BK4W5L77.USD","IE00BFSS8Q28.SGD","LU2237443549.SGD","LU1868837136.USD","IE00BJT1NW94.SGD","MHIP","LU0133085943.USD","LU1035775433.USD","LU0353189680.USD","LU1145028129.USD","SG9999015358.SGD","SG9999018857.SGD","LU0868494708.USD","LU0203347892.USD","VHT","LU2746668974.SGD","GDOC","LU0124676726.USD","LU2360032135.SGD","LU2111349929.HKD","LU1066053197.SGD","ELIS","LU2471134952.CNY","LU0316494557.USD","LU1571399168.USD","LU2896262040.SGD","IE00BJJMRY28.SGD","LU2552382215.SGD","LU0640476718.USD","LU0203201768.USD","LU0964807845.USD","LU1069344957.HKD","LU2433249047.HKD","LU0158827781.USD","TRUH","SG9999014559.SGD","LU2756315664.SGD","IE0002141913.USD","LU2471134796.USD","RXL","LU0061475181.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1989772840.SGD","LU1548497426.USD","LU1934455863.HKD","LU2264538146.SGD","SG9999015945.SGD","LU1280957306.USD","SG9999014567.USD","IE00BN29S564.USD","LU2756315318.SGD","LU0823416689.USD","LU1988902786.USD","LU0672654240.SGD","LU1929549753.HKD","LLYX","FHLC","HRTS","IE00BLSP4452.SGD","AGNG","LU1989771016.USD","LU2028103732.USD","LU0882574055.USD","SG9999015978.USD","LU0345770993.USD","LU1941712264.USD","LU1941712348.USD","LLYZ","LU2237438978.USD","SGXZ51526630.SGD","LU0058720904.USD","ELIL","LU2125909247.SGD","SG9999015986.USD","LU2168564495.EUR","LU0942090050.USD","LU0471298694.HKD","LU0210536198.USD","LU0266013472.USD","IE00B7KXQ091.USD","LU0882574139.USD","LU1868836591.USD","LU2491049909.HKD","LU2089984988.USD","LU0965509101.SGD","LU0130102774.USD","LU2211815571.USD","LU1093756168.USD","LU1201861249.SGD","LU1974910355.USD","IE00B4JS1V06.HKD","IE0005OL40V9.USD","LU1066051225.USD","LU0265550946.USD","LU2357305700.SGD","LU0889565916.HKD","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0823434740.USD","MEDX","SG9999017495.SGD","BK4585","PJP","PPH","LU1868837300.USD","IE00BWXC8680.SGD","XLV","LU2491050071.SGD","LU1868836757.USD","LU0323591593.USD","MEDI","BK4007","LU2236285917.USD","LU0965509010.AUD","LU2023250843.SGD","LU2750360997.AUD","LU0198837287.USD","LU0320765992.SGD","LU1061106388.HKD","LLII","LU1116320737.USD","SG9999014906.USD","LU1699723380.USD","BK4516","LU1712237335.SGD","LU1116320901.HKD","LU0122379950.USD","SG9999014880.SGD","BK4559","LU0859254822.USD","LU0786609619.USD","LU0985320562.USD","LU0648001328.SGD","IE00BJJMRX11.SGD","LU0238689110.USD","LU2106854487.HKD","IE00BJLML261.HKD","LU2456880835.USD","WDNA","LU0861579265.USD","LU0471298777.SGD","LU0683600562.USD","LU1064131342.USD","LU1037948541.HKD","SGXZ57979304.SGD","LU1551013342.USD","LU2324357040.USD","LU2168563687.JPY","LU1267930730.SGD","IE0004445015.USD","LU1691799644.USD","LU0820562030.AUD","LU1720051017.SGD","SGXZ31699556.SGD","LU1623119135.USD","LU0320765059.SGD","IE00BKDWB100.SGD","LU0432979614.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","GB00BDT5M118.USD","LU2237443382.USD","LU1127390331.HKD","IE00BBT3K403.USD","LU0096364046.USD","LU1023059063.AUD","LU1989772923.USD","LU0174119429.USD","LU2462591350.SGD","IE00B4R5TH58.HKD","IE00B1XK9C88.USD","LU0417517546.SGD","LU2361045086.USD","LU1804176565.USD","LU0130517989.USD","LU2168564065.EUR","LU2089283258.USD","IYH","IHE","LU1629891620.HKD","LU0868494617.USD","LU1057294990.SGD","TMED","LU2471134879.HKD","MRK","LU0823434583.USD","LU1366192091.USD","LU0070302665.USD","LU2468319806.SGD","SG9999001176.USD","IE0001KFT4U8.USD","LU0114720955.EUR","SG9999014575.USD","LU1430594728.SGD","LU2471134523.USD","LU2602419157.SGD","LU2168564222.USD","LU1551013425.SGD","LU0203345920.USD","LU0965508806.USD","LU0225283273.USD","BK4599","IE00BLSP4239.USD","SGXZ99366536.SGD","LU2023250330.USD","CURE","LU0787776722.HKD","SG9999014898.SGD","BK4581","LU0006306889.USD","LU1868836914.USD","LU2271345857.HKD","LU0203202063.USD","LU0211331839.USD","LU0820561909.HKD","SG9999001176.SGD","LU0980610538.SGD","IE0009355771.USD","SG9999002232.USD","SG9999001440.SGD","LU2023250504.SGD","LU0079474960.USD","LU1066051811.HKD","LU2125154935.USD","LU1983299246.USD","JDOC","LU1066051498.USD","LU0456855351.SGD","SG9999014542.SGD","LU0466842654.USD","LU1232071149.USD","LU1720051108.HKD","LU0256863811.USD","LU2265009873.SGD","LU2112291526.USD","LU0158827948.USD","LU1037948897.HKD","IE0004445239.USD","LU1035773651.USD","LU2237443465.HKD","IE00BK4W5M84.HKD","LU1162221912.USD","LU2108987350.USD","SG9999013999.USD","LU2360106947.USD","LU0320765489.SGD","LU1585245621.USD","LU0320765646.SGD","BK4533","SG9999002224.SGD","IE00BSNM7G36.USD","THNR","IE00B775H168.HKD","LU0256863902.USD","LU0234572021.USD","CANC","LU0106261372.USD","LU2491050154.USD","LU2125154778.USD","BK4588","FTXH","LU2089284900.SGD","LU0708995401.HKD","SG9999014914.USD","LU2552382132.HKD","LU2237443622.USD","ILDR","LU0345770308.USD","BK4534","SGXZ81514606.USD","LU0965509283.SGD","LU0354030511.USD","LU2746668461.USD","LU2063271972.USD","BMED","LU2750360641.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518829","title":"Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518829","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666518829?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065600,"startTime":"0","endTime":"0","summary":"Revolution Medicines barely had time to celebrate the landmark approval of its pancreatic cancer pill before Wall Street demanded to know what's next.Late last month, regulators approved daraxonrasib ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU1983299246.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1868836591.USD","BK4559","LU2133065610.SGD","LU0432979614.USD","LU2360032135.SGD","IHE","BK4534","IE0002141913.USD","LU0267386448.USD","LU0456855351.SGD","LU1868836757.USD","LU1236620750.USD","LU2125154935.USD","LU1093756168.USD","BK4585","LU1670710588.SGD","BBH","LU1430594728.SGD","IE00BSNM7G36.USD","LU0096364046.USD","LU0882574055.USD","IE0009354923.USD","LU1670711040.USD","IE0009355771.USD","BMY","IDNA","PTH","IE00BFXG1179.USD","CANC","LU0109394709.USD","LU0985481810.HKD","LU0868494617.USD","LU0114720955.EUR","LU1718418525.SGD","LU0237698245.USD","FTXH","LU0306806265.USD","LU1571399168.USD","BK4588","LU1032466523.USD","BK4581","LU1236620834.HKD","LU1585245621.USD","IE00BFTCPJ56.SGD","RVMD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666107590","title":"AbbVie Declares Quarterly Cash Dividend of $1.73 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666107590","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666107590?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:18","pubTimestamp":1789064322,"startTime":"0","endTime":"0","summary":"AbbVie declares quarterly cash dividend of $1.73 a shareAbbVie declared a quarterly cash dividend of $1.73 per share.Dividend payable Nov. 16, 2026, to stockholders of record as of Oct. 15, 2026.Discl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL5lD9cS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","TRUH","IYH","FTXH","LU2133065610.SGD","LU1023059063.AUD","LU2125909593.SGD","LU0738911758.USD","PJP","LU1093756325.SGD","LU1037948897.HKD","XLV","LU2089284900.SGD","LU2129689431.USD","LU1430594728.SGD","FHLC","LU1003077747.HKD","RXL","AGNG","LU0965509010.AUD","LU0289739343.SGD","LU1244550577.SGD","LU0234570918.USD","ABBV","IXJ","LU0985320562.USD","SG9999001440.SGD","IE0002141913.USD","LU1923622614.USD","PPH","JDOC","LU1496350171.SGD","LU2237443622.USD","LU0689472784.USD","IE00BVYPNW00.USD","LU2129689514.USD","LU2112291526.USD","LU0211327993.USD","LU0472753341.HKD","LU2433249047.HKD","LU2237443382.USD","VHT","LU2089283258.USD","IE00B4R5TH58.HKD","MEDX","LU1839511570.USD","GLAM","IE00BJT1NW94.SGD","LU1244550221.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590101","title":"Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666590101?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:18","pubTimestamp":1789064315,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0310799852.SGD","LU0310800379.SGD","IE00BLSP4239.USD","ABBV","JDOC","LU1074936037.SGD","LU2125909593.SGD","LU1496350171.SGD","RXL","SG9999015945.SGD","LU1267930573.SGD","XLV","LU2112291526.USD","BK4550","FHLC","LU0868494708.USD","LU2468319806.SGD","IXJ","PJP","LU0069063385.USD","BK4588","IE000WAW04H5.SGD","LU0949170772.SGD","LU1057294990.SGD","LU1162221912.USD","LU1496350502.SGD","LU1093756325.SGD","LU1236620834.HKD","LU1732799900.SGD","LU2087621335.USD","BK4581","LU0511384066.AUD","LU2237443622.USD","TRUH","FTXH","LU1244550577.SGD","IE0002270589.USD","LU1983299246.USD","LU0320765646.SGD","LU0985320562.USD","PPH","SG9999015978.USD","AGNG","IE000BZT7R73.USD","VHT","IYH","LU2237443465.HKD","BK4139","GLAM","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597348","title":"BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597348","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597348?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:31","pubTimestamp":1789057896,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb is running a late stage study that pi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bmy-targets-pediatric-ms-edge-with-new-ozanimod-study-against-fingolimod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bmy-targets-pediatric-ms-edge-with-new-ozanimod-study-against-fingolimod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","LU0321505439.SGD","LU0096364046.USD","LU1585245621.USD","LU1868837300.USD","BMY","LU2596442595.SGD","IHE","IE00BFXG1179.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU1670711123.USD","LU2242646821.SGD","LU1718418525.SGD","LU1868836591.USD","LU0306807586.USD","IE00BSNM7G36.USD","LU1074936037.SGD","LU1868837136.USD","LU1670710661.SGD","LU0432979614.USD","BK4581","LU0456855351.SGD","LU1670711040.USD","LU2360032135.SGD","LU1571399168.USD","BK4585","LU2125154935.USD","LU1236620834.HKD","LU0225771236.USD","FTXH","LU1430594728.SGD","BK4534","LU0306806265.USD","LU0882574055.USD","BK4559","LU1989771016.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1093756325.SGD","BK4532","LU1868836914.USD","IE0009355771.USD","LU1032466523.USD","BK4588","LU2125154778.USD","LU1236620750.USD","LU0321505868.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597351","title":"Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597351","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057847,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb Co. (BMY) has completed a long-term P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-long-term-psoriasis-study-brings-fresh-data-for-bmy-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-long-term-psoriasis-study-brings-fresh-data-for-bmy-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","IE00B2B36J28.USD","LU0114720955.EUR","LU0225284248.USD","LU1868836757.USD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU0225771236.USD","IE00BFTCPJ56.SGD","BK4534","LU1868837136.USD","LU1670710588.SGD","LU0868494617.USD","LU0306806265.USD","LU1670711040.USD","LU1670710661.SGD","FTXH","IE0009355771.USD","LU0985481810.HKD","BK4585","LU0321505868.SGD","IE0002141913.USD","BMY","LU1074936037.SGD","LU1291159041.SGD","LU1261432733.SGD","LU2125154778.USD","LU1236620834.HKD","LU2242652126.USD","LU0882574055.USD","LU1032466523.USD","LU1868836914.USD","LU1868837300.USD","LU2360032135.SGD","LU2596442595.SGD","BK4532","LU1670711123.USD","LU1236620750.USD","LU0321505439.SGD","LU1983299246.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU1323610961.USD","LU0432979614.USD","BK4559","IHE","ISBC","LU1718418525.SGD","BK4007","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597343","title":"Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597343","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597343?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057826,"startTime":"0","endTime":"0","summary":"ONO Pharmaceutical Co ($OPHLF), Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb and O...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bladder-cancer-trial-completion-puts-opdivo-in-focus-for-bmy-and-ono-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bladder-cancer-trial-completion-puts-opdivo-in-focus-for-bmy-and-ono-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2133065610.SGD","LU0306807586.USD","LU0225284248.USD","LU1868836757.USD","LU2360032135.SGD","LU0868494617.USD","LU1868836591.USD","LU1430594728.SGD","IE00BFXG1179.USD","LU0096364046.USD","LU0061475181.USD","LU1291159041.SGD","IHE","LU1093756168.USD","LU0225771236.USD","LU0882574055.USD","LU0114720955.EUR","LU1670711123.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","BMY","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU1236620750.USD","LU1670710661.SGD","BK4559","IE00BJT1NW94.SGD","LU1585245621.USD","LU0456855351.SGD","LU2242646821.SGD","ISBC","BK4007","FTXH","LU1868837136.USD","IE0009355771.USD","LU0267386448.USD","LU1074936037.SGD","IE0002141913.USD","LU0985481810.HKD","LU0321505439.SGD","BK4581","LU1670710588.SGD","LU1323610961.USD","LU2242652126.USD","BK4585","LU1093756325.SGD","LU1571399168.USD","LU1236620834.HKD","LU0321505868.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666973105","title":"AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666973105","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666973105?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057812,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is reporting new data from an observational eye study in adults with dia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-eye-implant-study-delivers-fresh-realworld-clarity-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-eye-implant-study-delivers-fresh-realworld-clarity-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0820561818.USD","LU1585245621.USD","TRUH","IYH","LU1061106388.HKD","LU0256863811.USD","FTXH","LU0256863902.USD","LU0211328371.USD","LU0738911758.USD","LU2237443895.HKD","PJP","LU0203345920.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU0417517546.SGD","XLV","LU2089284900.SGD","LU0868494617.USD","FHLC","LU1003077747.HKD","RXL","AGNG","LU0234570918.USD","ABBV","IXJ","LU2347655156.SGD","IE0002141913.USD","LU0795875169.SGD","PPH","JDOC","LU1496350171.SGD","ISBC","LU2468319806.SGD","BK4534","LU0320765646.SGD","IE00B2B36J28.USD","LU2433249047.HKD","IE000F7OJYX1.SGD","IE00BDGV0183.EUR","VHT","IE00B4R5TH58.HKD","LU0057025933.USD","LU0726765562.USD","MEDX","LU1839511570.USD","GLAM","IE00BJT1NW94.SGD","IE00BBT3K403.USD","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666466592","title":"Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666466592","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666466592?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:08","pubTimestamp":1789056517,"startTime":"0","endTime":"0","summary":"Cytokinetics (CYTK) likely has the upper hand in its patent dispute with Bristol-Myers Squibb (BMY) related to a patent for methods of treatment with cardiac myosin inhibitors, or CMIs, RBC Capital Ma","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1670711123.USD","LU1093756168.USD","LU0267386448.USD","LU1670710588.SGD","LU1718418525.SGD","BK4532","FTXH","LU0225284248.USD","LU2133065610.SGD","LU2360032135.SGD","LU1989771016.USD","LU1868836591.USD","LU1093756325.SGD","BMY","LU2242652126.USD","IHE","LU1074936037.SGD","BK4007","IE00BJJMRZ35.SGD","LU0237698245.USD","LU2596442595.SGD","IE0009355771.USD","LU0306807586.USD","LU1430594728.SGD","LU0321505439.SGD","LU0061475181.USD","LU2125154935.USD","BK4139","IE0002141913.USD","BK4559","LU0114720955.EUR","LU1868836914.USD","LU1291159041.SGD","CYTK","BK4505","BK4534","IE00B2B36J28.USD","LU0306806265.USD","LU0985481810.HKD","LU0225771236.USD","LU1032466523.USD","LU1323610961.USD","LU1236620750.USD","LU1868837136.USD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1868836757.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659414","title":"Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659414","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659414?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:04","pubTimestamp":1789052640,"startTime":"0","endTime":"0","summary":"Wachtell dealmaker jumps to Linklaters to bolster US buildoutSept 10 (Reuters)-Law firm Linklaters said on Thursday that it has hired longtime partner Mark Gordon from Wachtell, Lipton, Rosen & Katz, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL6N4520WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU1989771016.USD","FHLC","LU0496365809.HKD","LU2750360997.AUD","LU0708994859.HKD","LU0072461881.USD","LU0689472784.USD","TRUH","LU0960981461.USD","LU2293690082.USD","XLV","IE00BLSP4452.SGD","LU0053666078.USD","JHX","IXJ","LU1814569148.SGD","IHE","IE00BDGV0183.EUR","IE00B4R5TH58.HKD","LU0972486137.USD","RXL","LU1880407215.USD","LU2089284900.SGD","LU1829250122.USD","AZN.UK","LU1355424745.HKD","LU2430703095.HKD","LU1323610961.USD","03165","IE000SO60NU8.SGD","LU0949170426.SGD","LU2089283258.USD","LU0077335932.USD","BMED","LU2112291526.USD","VHT","PJP","FTXH","LU0210536198.USD","IE00B3PB1722.GBP","MEDX","JDOC","LU0211326839.USD","LU1084165304.USD","LU1291159041.SGD","GDOC","LU0466842654.USD","IE00BVYPNW00.USD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":4,"totalSize":209,"code":"91000000","status":"200"}]}}